P2RY12 Gene Bleeding Disorder Platelet-Type 8 Genetic Test
Test Name: P2RY12 Gene Bleeding Disorder Platelet-Type 8 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Hematology
Doctor: Hematologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for P2RY12 Gene Bleeding Disorder, Platelet-Type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with P2RY12 Gene Bleeding Disorder, Platelet-Type 8 NGS Genetic DNA Test gene P2RY12.
Test Details: The P2RY12 gene is responsible for producing a protein called P2Y12 receptor, which is found on the surface of platelets. Platelets are small blood cells that play a crucial role in blood clotting. When a blood vessel is damaged, platelets adhere to the site and form a plug to stop bleeding. However, mutations in the P2RY12 gene can lead to a bleeding disorder known as platelet-type 8. This condition is characterized by abnormal platelet function, resulting in an increased risk of bleeding and difficulty in forming blood clots.
To diagnose platelet-type 8, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes, including the P2RY12 gene. This test involves extracting DNA from a blood sample and sequencing the P2RY12 gene to identify any genetic variants or mutations.
NGS genetic testing for platelet-type 8 can help confirm a diagnosis, guide treatment decisions, and provide information about the inheritance pattern of the condition. It can also be useful for identifying carriers of the gene mutation within families.
Treatment for platelet-type 8 may involve medications that inhibit platelet function, such as aspirin or clopidogrel. In severe cases, platelet transfusions may be necessary to control bleeding episodes.
It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics, as they can provide appropriate counseling and guidance based on the test results.
Test Name | P2RY12 Gene Bleeding disorder platelet-type 8 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hematology |
Doctor | Hematologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for P2RY12 Gene Bleeding disorder, platelet-type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with P2RY12 Gene Bleeding disorder, platelet-type 8 NGS Genetic DNA Test gene P2RY12 |
Test Details |
The P2RY12 gene is responsible for producing a protein called P2Y12 receptor, which is found on the surface of platelets. Platelets are small blood cells that play a crucial role in blood clotting. When a blood vessel is damaged, platelets adhere to the site and form a plug to stop bleeding. However, mutations in the P2RY12 gene can lead to a bleeding disorder known as platelet-type 8. This condition is characterized by abnormal platelet function, resulting in an increased risk of bleeding and difficulty in forming blood clots. To diagnose platelet-type 8, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes, including the P2RY12 gene. This test involves extracting DNA from a blood sample and sequencing the P2RY12 gene to identify any genetic variants or mutations. NGS genetic testing for platelet-type 8 can help confirm a diagnosis, guide treatment decisions, and provide information about the inheritance pattern of the condition. It can also be useful for identifying carriers of the gene mutation within families. Treatment for platelet-type 8 may involve medications that inhibit platelet function, such as aspirin or clopidogrel. In severe cases, platelet transfusions may be necessary to control bleeding episodes. It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics, as they can provide appropriate counseling and guidance based on the test results. |